10-Q
Quarterly Report
AGENUS INC
AGEN
NASDAQ
CIK: 1098972
File #: 000-29089
Balance Sheet
47 line items · 2 periods
XBRL
| Item | Sep 30, 2024 | Dec 31, 2023 |
|---|---|---|
ASSETS | ||
Cash and cash equivalents | 44,784,000 | 76,110,000 |
Cost | 42,886,000 | 70,485,000 |
Estimated Fair Value | 42,886,000 | 70,485,000 |
Institutional Money Market Funds - Cost | 42,886,000 | 70,485,000 |
Institutional Money Market Funds - Estimated Fair Value | 42,886,000 | 70,485,000 |
Accounts receivable | 207,000 | 25,836,000 |
Prepaid expenses | 2,352,000 | 8,098,000 |
Other current assets | 2,811,000 | 2,372,000 |
Total current assets | 50,154,000 | 112,416,000 |
Property, plant and equipment, net of accumulated amortization and depreciation of $71,109 and $61,943 at September 30, 2024 and December 31, 2023, respectively | 124,472,000 | 133,421,000 |
Operating lease right-of-use assets | 28,612,000 | 29,606,000 |
Goodwill | 24,694,000 | 24,723,000 |
Acquired intangible assets, net of accumulated amortization of $18,063 and $17,688 at September 30, 2024 and December 31, 2023, respectively | 3,955,000 | 4,411,000 |
Other long-term assets | 6,595,000 | 9,336,000 |
Total assets | 238,482,000 | 313,913,000 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
Current portion, long-term debt | 13,401,000 | 146,000 |
Current portion, liability related to sale of future royalties and milestones | 159,647,000 | 132,502,000 |
Current portion, deferred revenue | 10,000 | 18,000 |
Current portion, operating lease liabilities | 2,427,000 | 2,587,000 |
Accounts payable | 45,899,000 | 61,446,000 |
Accrued liabilities | 36,695,000 | 45,283,000 |
Other current liabilities | 12,565,000 | 13,915,000 |
Total current liabilities | 270,644,000 | 255,897,000 |
Long-term debt, net of current portion | 0 | 12,768,000 |
Liability related to sale of future royalties and milestones, net of current portion | 182,558,000 | 124,556,000 |
Deferred revenue, net of current portion | 1,143,000 | 1,143,000 |
Operating lease liabilities, net of current portion | 55,164,000 | 62,511,000 |
Other long-term liabilities | 777,000 | 5,420,000 |
STOCKHOLDERS" DEFICIT | ||
Series A-1 convertible preferred stock | 0 | 0 |
Common stock, par value $0.01 per share; 800,000,000 shares authorized; 21,685,192 and 19,718,662 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively | 217,000 | 197,000 |
Additional paid-in capital | 1,845,815,000 | 1,796,095,000 |
Accumulated other comprehensive loss | (1,347,000) | (955,000) |
Accumulated deficit | (2,137,021,000) | (1,955,668,000) |
Total stockholders' deficit attributable to Agenus Inc. | (292,336,000) | (160,331,000) |
Non-controlling interest | 20,532,000 | 11,949,000 |
Non-controlling Interest | 20,532,000 | 11,949,000 |
Total stockholders' deficit | (271,804,000) | (148,382,000) |
Accumulated Other Comprehensive Income (Loss) | (1,347,000) | (955,000) |
Accumulated Deficit | (2,137,021,000) | (1,955,668,000) |
Non-controlling Interest | 20,532,000 | 11,949,000 |
Series A-1 convertible preferred stock - Preferred Stock | 0 | 0 |
Common Stock | 217,000 | 197,000 |
Additional Paid-in Capital | 1,845,815,000 | 1,796,095,000 |
Total liabilities and stockholders' deficit | 238,482,000 | 313,913,000 |